This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Mannitol

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Mannitol is a fast acting osmotic diuretic that may be used in the treatment of cerebral oedema. It reduces intracranial ressure by establishing an osmotic gradient between the plasma and the brain tissue. The effects persist for 4 to 6 hours. It is usually administered IV as a 20% solution.

Mannitol should be used as an emergency treatment or to 'buy' time prior to surgery for a mass lesion. Repeated infusions may cause equilibration and a high intracellular osmotic pressure, so counteracting further treatment. Additionally, it may precipitate lethal rises in arterial blood pressure and acute tubular necrosis.

Also, mannitol may be used in the treatment of haemochromogenuria.

It is contraindicated in congestive heart failure and pulmonary oedema.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.